Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT400 vs Rituximab PK Study in B-cell NHL
NCT02456207Phase 2Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ripertamab in B-cell non-Hodgkin lymphoma, sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
ripertamab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02456207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456207.